Quarterly Consolidated Balance Sheet

KYORIN Pharmaceutical Co., Ltd. - Filing #7550544

Concept As at
2023-06-30
As at
2023-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
18,637,000,000 JPY
19,394,000,000 JPY
Merchandise and finished goods
17,532,000,000 JPY
19,074,000,000 JPY
Work in process
9,870,000,000 JPY
9,079,000,000 JPY
Raw materials and supplies
20,655,000,000 JPY
19,872,000,000 JPY
Other
4,926,000,000 JPY
4,349,000,000 JPY
Allowance for doubtful accounts
-37,000,000 JPY
-41,000,000 JPY
Current assets
114,447,000,000 JPY
119,030,000,000 JPY
Non-current assets
Property, plant and equipment
26,246,000,000 JPY
25,834,000,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
5,288,000,000 JPY
5,393,000,000 JPY
Investments and other assets
26,559,000,000 JPY
25,785,000,000 JPY
Investments and other assets
Investment securities
23,404,000,000 JPY
22,979,000,000 JPY
Deferred tax assets
1,141,000,000 JPY
1,316,000,000 JPY
Other
1,908,000,000 JPY
1,519,000,000 JPY
Allowance for doubtful accounts
-29,000,000 JPY
-29,000,000 JPY
Non-current assets
58,094,000,000 JPY
57,014,000,000 JPY
Assets
172,542,000,000 JPY
176,045,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
11,699,000,000 JPY
13,762,000,000 JPY
Short-term borrowings
10,300,000,000 JPY
10,300,000,000 JPY
Income taxes payable
354,000,000 JPY
2,027,000,000 JPY
Other
8,735,000,000 JPY
6,710,000,000 JPY
Current liabilities
32,206,000,000 JPY
34,983,000,000 JPY
Non-current liabilities
Long-term borrowings
10,586,000,000 JPY
10,636,000,000 JPY
Retirement benefit liability
3,762,000,000 JPY
3,721,000,000 JPY
Other
763,000,000 JPY
776,000,000 JPY
Non-current liabilities
15,583,000,000 JPY
15,600,000,000 JPY
Liabilities
47,789,000,000 JPY
50,584,000,000 JPY
Net assets
Shareholders' equity
Share capital
700,000,000 JPY
700,000,000 JPY
Capital surplus
4,752,000,000 JPY
4,752,000,000 JPY
Retained earnings
133,212,000,000 JPY
134,396,000,000 JPY
Treasury shares
-17,666,000,000 JPY
-17,666,000,000 JPY
Shareholders' equity
120,998,000,000 JPY
122,182,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
6,009,000,000 JPY
5,695,000,000 JPY
Foreign currency translation adjustment
404,000,000 JPY
340,000,000 JPY
Remeasurements of defined benefit plans
-2,658,000,000 JPY
-2,756,000,000 JPY
Valuation and translation adjustments
3,754,000,000 JPY
3,278,000,000 JPY
Net assets
124,753,000,000 JPY
125,461,000,000 JPY
Liabilities and net assets
172,542,000,000 JPY
176,045,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.